Jan 11, 2017

AbbVie moves to keep price increases down

At the JP Morgan Healthcare Conference in San Francisco today, AbbVie CEO Richard Gonzalez vowed to keep drug price increases below 10%. AbbVie is joining Allergan and Novo Nordisk in setting a ceiling on price increases.

Talk about timing: Gonzalez spoke after Trump took slugs at the pharmaceutical industry during his press conference. AbbVie shares, along with the rest of the pharmaceutical industry, fell sharply--AbbVie ended up down 3.6%

Go deeper